{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T05:54:32Z","timestamp":1723010072897},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Two simple, accurate and precise chromatographic methods have been developed and validated for estimating Mupirocin (MUP) in two binary mixtures. Mixture (1); with Fluticasone propionate (FLU) together with two of their impurities, namely; Pseudomonic acid-D (Pseud-D) and Fluticasone impurity C (FIC). Mixture (2); with Mometasone furoate (MF) along with Pseud-D impurity. High performance thin layer chromatography (HPTLC-densitometry) and high performance liquid chromatography (RP-HPLC) were the two proposed methods. In the HPTLC method, good separation of both mixtures was achieved by using HPTLC plates pre-coated with silica gel 60 F<jats:sub>254<\/jats:sub> as stationary phase and the mobile phase consisted of toluene: chloroform: ethanol at a ratio of (5: 4: 2, by volume). The detection was carried out at 220\u00a0nm for MUP and 254\u00a0nm for FLU, MF, Pseud-D and FIC. In the HPLC method, chromatographic separation was carried out using Agilent Eclipse XDB (250\u00a0mm\u00d74.6\u00a0mm, 5\u00a0\u03bcm) C18 column. For mixture (1), a mobile phase of methanol: sodium di-hydrogen phosphate (pH 3.0) was applied in stepwise gradient elution starting at ratios of (50: 50, v\/v) and then switching to (80: 20, v\/v) after 7\u00a0min at a flow rate of 1 mL.min<jats:sup>\u2212\u20091<\/jats:sup>. Detection was performed using diode array detector at 220\u00a0nm for MUP and Pseud-D and 240\u00a0nm for FLU and FIC. For mixture (2), the same mobile phase was used, but in isocratic elution in the ratio (80: 20, v\/v) at flow rate of 1 mL.min<jats:sup>\u2212\u20091<\/jats:sup> and detection at 220\u00a0nm for MUP and Pseud-D and 248\u00a0nm for MF. The two methods successfully separated the cited drugs and were used to determine the drugs in pure form as well as pharmaceutical dosage forms. Validation was done as per International Council on Harmonization guidelines. Furthermore, the greenness of the proposed methods compared to the reported method, was evaluated as per the National Environmental Method Index, analytical Eco scale, Green Analytical Procedure Index and Analytical Greenness metric approaches.<\/jats:p>","DOI":"10.1186\/s13065-023-01055-5","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T16:01:46Z","timestamp":1698422506000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Greenness assessment of two chromatographic methods developed for the determination of Mupirocin in two binary mixtures along with its impurity"],"prefix":"10.1186","volume":"17","author":[{"given":"Maha M.","family":"Galal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaaban A.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola Y.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza A.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"1055_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trac.2013.04.010","volume":"50","author":"A Ga\u0142uszka","year":"2018","unstructured":"Ga\u0142uszka A, Migaszewski Z, Namie\u00b4snik J. The 12 principles of green analytical chemistry and the significance mnemonic of green analytical practices, TrAC. Trends Anal Chem. 2018;50:78\u201384.","journal-title":"Trends Anal Chem"},{"key":"1055_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-022-00904-z","volume":"16","author":"MA Abdel Rahman","year":"2022","unstructured":"Abdel Rahman MA, Elghobashy MR, Zaazaa HE, Atty SA. El\u2013Mosallamy, validated HPLC\u2013PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of paracetamol toxic impurities. BMC Chem. 2022;16:1\u201311.","journal-title":"BMC Chem"},{"key":"1055_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.arabjc.2014.10.051","volume":"12","author":"A Badr Eldin","year":"2019","unstructured":"Badr Eldin A, Shalaby A, Abdullah MS, Shaldam MA, Abdullah MA. Applying green analytical chemistry (GAC) for development of stability indicating HPLC method for determining clonazepam and its related substances in pharmaceutical formulations and calculating uncertainty. Arab J Chem. 2019;12:1212\u20138.","journal-title":"Arab J Chem"},{"key":"1055_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jsps.2018.07.007","volume":"26","author":"EA Abdelaleem","year":"2018","unstructured":"Abdelaleem EA, Abdelwahab NS. Green chromatographic method for analysis of some anti-cough Drugs and their toxic impurities with comparison to conventional methods. Saudi Pharm J. 2018;26:1185\u201391.","journal-title":"Saudi Pharm J"},{"key":"1055_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.12973\/ejac\/78054","volume":"2","author":"SB Bari","year":"2007","unstructured":"Bari SB, Kadam BR, Jaiswal YS, Shirkhedkar A. Impurity profile: significance in active pharmaceutical ingredient. Eurasian J Anal Chem. 2007;2:32\u201356.","journal-title":"Eurasian J Anal Chem"},{"key":"1055_CR6","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Impurities in New Drug Substances Q3a (R2)., (2006)."},{"key":"1055_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trac.2006.05.012","volume":"25","author":"SW Baertschi","year":"2006","unstructured":"Baertschi SW. Analytical methodologies for discovering and profiling degradation-related impurities, TrAC. Trends Anal Chem. 2006;25:758\u201367.","journal-title":"Trends Anal Chem"},{"key":"1055_CR8","volume-title":"British Pharmacopoeia Commission","author":"British","year":"2016","unstructured":"British, Pharmacopoeia. British Pharmacopoeia Commission. Volume II. London: TSO; 2016."},{"key":"1055_CR9","volume-title":"United States Pharmacopeial Convention, Asian edition","author":"The United States pharmacopeia 41","year":"2019","unstructured":"The United States pharmacopeia 41. United States Pharmacopeial Convention, Asian edition. Volume II. Rockville: MD; 2019."},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.biopha.2018.10.131","volume":"109","author":"S Khoshnooda","year":"2019","unstructured":"Khoshnooda S, Heidary M, Asadi A, Soleimani S, Motahara M, Savaria M, Sakia M. Abdia A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomed Pharmacother. 2019;109:1809\u201318.","journal-title":"Biomed Pharmacother"},{"key":"1055_CR11","first-page":"125","volume":"11","author":"HN Davea","year":"2013","unstructured":"Davea HN, Makwanab AG, Suhagiac BN. Validated reversed Phase High Performance Liquid Chromatographic Method for determination of three novel steroids in bulk and pressurized metered \u2013 dose commercial preparations using a common Mobile Phase International. J Appl Sci Eng Int J Appl Sci Eng. 2013;11:125\u201335.","journal-title":"J Appl Sci Eng Int J Appl Sci Eng"},{"key":"1055_CR12","first-page":"4411","volume":"11","author":"A Khristi","year":"2020","unstructured":"Khristi A, Prajapati N. Development and validation of RP-HPLC method for estimation of Fluticasone Propionate and Mupirocin in a combined topical dosage form. IJPSR. 2020;11:4411\u20139.","journal-title":"IJPSR"},{"key":"1055_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.22159\/ajpcr.2019.v12i4.31279","volume":"12","author":"RB Pharate","year":"2019","unstructured":"Pharate RB, Dhaneshwar SS. Stability Indicating High-Performance Thin-Layer Chromatography Method for simultaneous estimation of Formoterol Fumarate dihydrate and Fluticasone Propionate in Bulk Drug and Pharmaceutical Dosage Form. Asian J Pharm Clin Res. 2019;12:149\u201355.","journal-title":"Asian J Pharm Clin Res"},{"key":"1055_CR14","first-page":"187","volume":"20","author":"P Dalvi","year":"2008","unstructured":"Dalvi P, Filmwala Z, Bane TV. Ultra Performance Liquid Chromatography Method for Fluticasone Propionate. Asian J Chem. 2008;20:187\u201394.","journal-title":"Asian J Chem"},{"key":"1055_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/chromsci\/47.2.178","volume":"47","author":"S Shaikh","year":"2009","unstructured":"Shaikh S, Muneera MS, Thusleem OA, Tahir M, Kondaguli A. RP-HPLC method for the simultaneous quantitation of Chlorocresol, Mometasone Furoate and Fusidic Acid in creams. J Chromatogr Sci. 2009;47:178\u201383.","journal-title":"J Chromatogr Sci"},{"key":"1055_CR16","first-page":"758","volume":"6","author":"AP Parmar","year":"2015","unstructured":"Parmar AP, Maheshwari DG. Development and Validation of Analytical Method for Simultaneous Estimation of Mupirocin and Mometasone Furoate in Topical Formulation by RP-HPLC. Int J Pharm Sci. 2015;6:758\u201366.","journal-title":"Int J Pharm Sci"},{"key":"1055_CR17","first-page":"3647","volume":"4","author":"RVVSP Kumari","year":"2017","unstructured":"Kumari RVVSP, Mangamma K, Prasad SVUM. Stability indicating RP-HPLC Method Development and Validation for the simultaneous estimation of Mupirocin and Fluticasone Propionate. Indo Am j Pharm Sci. 2017;4:3647\u201356.","journal-title":"Indo Am j Pharm Sci"},{"key":"1055_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/chromatography2040642","volume":"2","author":"T Purvis","year":"2015","unstructured":"Purvis T. Simultaneous high performance liquid chromatography assay of Pentoxifylline, Mupirocin, Itraconazole, and Fluticasone Propionate in Humco\u2122 Lavare Wound Base. Chromatogr. 2015;2:642\u201354.","journal-title":"Chromatogr"},{"key":"1055_CR19","first-page":"1","volume":"5","author":"A Parmar","year":"2015","unstructured":"Parmar A, Maheshwari D. Simultaneous estimation of Mupirocin and Mometasone Furoate in Pharmaceutical Dosage Form by Q-Absorption ratio Method. Int J Pharm Sci Res. 2015;5:1\u20137.","journal-title":"Int J Pharm Sci Res"},{"key":"1055_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.arabjc.2013.04.016","volume":"10","author":"MR Siddiquia","year":"2017","unstructured":"Siddiquia MR, AlOthmana ZA, Rahmanb N. Analytical techniques in pharmaceutical analysis: a review. Arab J chem. 2017;10:1409\u201321.","journal-title":"Arab J chem"},{"key":"1055_CR21","first-page":"1","volume":"00","author":"MA Tantawy","year":"2022","unstructured":"Tantawy MA, Abdulla SA, Mohamed OY. Abou Al- Alamein, normal phase TLC and gradient reversed Phase HPLC for the simultaneous determination of Enrofloxacin and Bromhexine HCl in Presence of two of their official impurities. J Chromatogr Sci. 2022;00:1\u20136.","journal-title":"J Chromatogr Sci"},{"key":"1055_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1556\/1006.2018.31.4.3","volume":"31","author":"AMA Al Alamein","year":"2018","unstructured":"Al Alamein AMA, Saad AS. Galal, a comparative study of different chromatographic techniques for determination of toxic impurities of some commonly used anesthetics. JPC-J Planar Chromat. 2018;31:280\u20139.","journal-title":"JPC-J Planar Chromat"},{"key":"1055_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/2229-4708.84436","volume":"2","author":"M Attimard","year":"2011","unstructured":"Attimard M, Ahmed KM, Aldhubaib BE, Harsha S. High-performance thin layer chromatography: a powerful analytical technique in pharmaceutical drug discovery. Pharm Methods. 2011;2:71\u20135.","journal-title":"Pharm Methods"},{"key":"1055_CR24","first-page":"1","volume-title":"High-performance Thin-Layer Chromatogr","author":"PS Variyar","year":"2011","unstructured":"Variyar PS, Chatterjee S, Sharma A. Fundamentals and Theory of HPTLC-Based separation. In: Srivastava M, editor. High-performance Thin-Layer Chromatogr. Berlin: Springer-Verlag; 2011. pp. 1\u2013397."},{"key":"1055_CR25","volume-title":"Fundamentals of analytical chemistry","author":"DA Skoog","year":"2014","unstructured":"Skoog DA, West DM, Holler FJ, Crouch SR. Fundamentals of analytical chemistry. Ninth ed. USA: Brooks\/Cole; 2014.","edition":"Ninth"},{"key":"1055_CR26","first-page":"2695","volume":"107","author":"LH Keith","year":"2007","unstructured":"Keith LH, Gron LU, Young JL. Green Anal Methodologies Chem Rev. 2007;107:2695\u2013708.","journal-title":"Green Anal Methodologies Chem Rev"},{"key":"1055_CR27","doi-asserted-by":"crossref","unstructured":"Ga\u0142uszka A, Konieczka P, Migaszewski ZM, Namiesnik J. Analytical Eco-scale for assessing the greenness of analytical procedures, 37 (2012) 61\u201372.","DOI":"10.1016\/j.trac.2012.03.013"},{"key":"1055_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka J. A new tool for the evaluation of the analytical procedure: green analytical procedure index. Talanta. 2018;181:204\u20139.","journal-title":"Talanta"},{"key":"1055_CR29","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE- Analytical Greenness metric approach and software. J Anal Chem. 2020;92:10076\u201382.","journal-title":"J Anal Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-01055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-023-01055-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-01055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T16:02:43Z","timestamp":1698422563000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-023-01055-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1186\/s13065-023-01055-5","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}